To showcase how people living with ITP triumph and persevere, Novartis partnered with photographer Kate T. Parker on a series of photo essays.

Novartis is investing in a novel type of medicine to reduce the risk of heart disease.

Novartis investigators find genetic explanations for why some young patients relapse.

Combination of two compounds shows promise in the lab

Novartis researchers are working to extend the life of organ transplants

Novartis data scientists are using super-resolution microscopy to see neurodegeneration the moment it starts.

Molecular glues are a new type of medicine inspired by nature’s matchmakers.

In Wendi Yajnik’s quest to find new technologies that could transform medicine, relationships are priority No. 1.